BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

5:21 PM
 | 
Feb 11, 2010
 |  BC Extra  |  Company News

OxiGene restructuring

OxiGene Inc. (NASDAQ:OXGN; SSE:OXGN) will restructure and reduce headcount by 20 (49%) to conserve cash. OxiGene also will stop further enrollment in the Phase II/III FACT trial of Zybrestat fosbretabulin to treat advanced...

Read the full 151 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >